SAT-198 ASC41, a selective THRβ agonist significantly reduces liver fat and ALT in biopsy-confirmed MASH patients after 12-week treatment: an interim analysis of a 52-week serial liver biopsy study
Jian‐Gao Fan, Junping Shi, Hong Wang, Ming‐Hua Zheng, Jinjun Chen, Yao Xie, Fangfang Lv, Sikui Wang, Ling Yang, Qing Xie, Yueqiu Gao, Chuanwu Zhu, Xuebing Yan, Qiya Huang, Bin Xu, Fei Liu, Honglian Bai, Hong Deng, Airong Hu, Xin Gao, Guo‐Xin Hu, Hong You, Hong Tang, Min Zhang, Xiaoling Chi, Qin Du, Xiaoping Wu, Hongzhou Lu, Yuguo Zhang, Guizhou Zou, Huanwei Zheng, Yujuan Guan, Yue Chen, Hua Ye, Tianhuang Liu, Yue-Mei Yan, Jinzi J. Wu
Cited by 1Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis